Comment & Analysis

If AstraZeneca’s chief executive, Pascal Soriot, is today shouting down the phone at some seriously ...

Two days ago Ionis Pharmaceuticals was in a sorry state: safety concerns with its orphan disease ...

EP Vantage will not publish on Monday May 30 owing to a holiday.



Therapeutic Focus

Market Moving Events

EP Vantage Interviews